Developing and validating bioanalytical methods is no easy task. In this video, Erik Jerks of Eurofins Clinical Trial Solutions shares strategies for overcoming challenges in assay development for bispecific multitarget antibodies and AAV-based drugs: https://www.selectscience.net/video/strategies-for-bioanalytical-method-development-and-validation #Bioanalysis #PharmaResearch | SelectScience

Genetic technologies can add efficiency to your biopharmaceutical asset development and bring essential competitive advantage to your programs. Download to learn: •How genetic analysis is enabling more rapid and efficient clinical trials •How integration of genetic analysis technologies is evolving in the pharma and biotech spaces •How companies around the world are deploying genetic analysis to gain competitive advantage | Applied Biosystems